RemeGen Ltd. Class A Profit Margin

RemeGen Ltd. Class A posts a profit margin of 78.75% as of September 2026. That compares with -42.62% in the prior-year period — up 284.8% year over year. That is above the Healthcare sector average of 10.58%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, RemeGen Ltd. Class A's profit margin was -42.62%. The latest reading is 78.75% — a 284.8% year-over-year increase (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 10.58% is typical. RemeGen Ltd. Class A's 78.75% is higher that level. That is roughly 644.3% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

RemeGen Ltd. Class A's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 78.75% as of September 2026; use YoY and peer views to separate noise from signal.

Context for 688331.SS's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 10.58%), and (3) consistency with growth and profitability. This page covers the first two; RemeGen Ltd. Class A's other metric pages and overview cover the third.